Budesonide (Shire)

布地奈德 (Shire)

Report date: 2025/11/27 15:17:28

Base Information

Drug NameBudesonide (Shire)
Drug Alias NameBudesonide oral suspension - Takeda布地缩松Oral viscous budesonide信必可都保Budesonidum (Shire) +[11] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsEosinophilic Esophagitis
Global Approved IndicationsEosinophilic Esophagitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/02/09
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVerus Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceuticals USA Inc
Inactive CompaniesShireTakeda Pharmaceutical Co LtdTakeda Development Center Americas Inc
Active IndicationsEosinophilic Esophagitis
Inactive IndicationsN/A

Other Information

ATC CodeA07EA06D07AC09R01AD05 +[4] 
Related LinksN/A